In addition to its intracellular activity, legumain can be secreted into the tumor microenvironment (TME) in which it contributes to degrading and remodeling the ECM [16, 167], either by producing the mature forms of MMP2 and MMP9 [16, 168] or by processing cathepsins [169]. This evidence concerns the gene MMP9 and neoplasm.